KR0150566B1 - A process for preparing stereo active 3-amino heterocyclic compound - Google Patents

A process for preparing stereo active 3-amino heterocyclic compound

Info

Publication number
KR0150566B1
KR0150566B1 KR1019950012330A KR19950012330A KR0150566B1 KR 0150566 B1 KR0150566 B1 KR 0150566B1 KR 1019950012330 A KR1019950012330 A KR 1019950012330A KR 19950012330 A KR19950012330 A KR 19950012330A KR 0150566 B1 KR0150566 B1 KR 0150566B1
Authority
KR
South Korea
Prior art keywords
amino
compound
formula
general formula
derivative
Prior art date
Application number
KR1019950012330A
Other languages
Korean (ko)
Other versions
KR960041163A (en
Inventor
문성환
이수진
Original Assignee
이병언
주식회사중외제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 이병언, 주식회사중외제약 filed Critical 이병언
Priority to KR1019950012330A priority Critical patent/KR0150566B1/en
Publication of KR960041163A publication Critical patent/KR960041163A/en
Application granted granted Critical
Publication of KR0150566B1 publication Critical patent/KR0150566B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/12Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/44Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/12Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 천연중에 풍부하게 존재하는 α-아미노산인, L-글루타민산, L-아디픽산 또는 그의 광학이성질체들을 출발물질로하여, 광학활성이 있는 보호된 3-아미노피페리딘 유도체 또는 3-아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀 유도체등의 3-아미노 헤테로고리아민유도체를 제조하는 방법에 관한 것이다.The present invention is a protected 3-aminopiperidine derivative or 3-amino- with optical activity, using as starting materials L-glutamic acid, L-adipic acid or optical isomers thereof, which are a-amino acids which are abundant in nature. A method for producing 3-amino heterocyclic amine derivatives such as 2,3,4,5,6,7-hexahydro-1H-azepine derivative.

Description

광학활성이 있는 3-아미노 헤테로고리아민 유도체의 제조방법Method for preparing 3-amino heterocyclic amine derivative having optical activity

본 발명은 천연중에 풍부하게 존재하는 α-아미노산(L- 또는 D-)을 출발 물질로하여, 광학활성이 있는 3-아미노 헤테로고리아민 유도체를 제조하는 방법에 관한 것이다.The present invention relates to a method for producing an optically active 3-amino heterocyclic amine derivative using a-amino acid (L- or D-), which is present in abundance in nature, as a starting material.

하기식(I)의 광학활성이 있는 광학활성이 있는 3-아미노 헤테로고리아민 유도체들은 이미 공지된 화합물 또는 그의 유도체들로써, 광학활성촉매, 합성원료, 농약 또는 의약분야 특히 퀴놀논의약품 및 항암제의 중간체로 유용하다.The optically active 3-amino heterocyclic amine derivatives of the following formula (I) are known compounds or derivatives thereof, and are intermediates of optically active catalysts, synthetic raw materials, agrochemicals or pharmaceutical fields, especially quinolone drugs and anticancer agents. Useful as

종래에는 광학불활성의 라세미화합물로서 3-아미노 헤테로고리아민 유도체들이 여러방법으로 합성되어 퀴놀논계의 항균제에 널리 이용되어 왔다.Conventionally, 3-amino heterocyclic amine derivatives as optically inactive racemic compounds have been synthesized in various ways and widely used in quinolone-based antimicrobial agents.

3-아미노 헤테로고리아민 유도체중 6-환고리화합물인 3-아미노 피페리딘 유도체의 합성은 광학불활성의 라세미화합물로써 3-아미노 피리딘을 출발물질로 하여 3-4 단계를 거쳐 합성하는 방법 및 광학활성이 있는 3-아미노 피페리딘 유도체의 합성의 경우에는 L- 또는 D-오르니틴 염소산화합물을 출발물질로 하여 3-단계를 거쳐 합성하는 방법(참고, 일본 공개특허 평3-95177호, 유럽 공개특허 제342675호 및 Heterocycles, 1993, 36(10), 2383-96)이 개시되어 있으나, 백금등의 금속을 이용하거나 고압반응이므로 생산비용이 매우 높거나, 수율이 매우 저조하였다.Synthesis of 3-amino piperidine derivatives, which are 6-cyclic ring compounds among 3-amino heterocyclic amine derivatives, is a method of synthesizing a 3-amino pyridine compound as a starting material through 3-4 steps as an optically inactive racemic compound, and In the case of synthesis of an optically active 3-amino piperidine derivative, a method of synthesizing L- or D-ornithine chlorate as a starting material through three steps (see Japanese Patent Laid-Open No. 3-95177, European Patent Publication No. 342675 and Heterocycles, 1993, 36 (10), 2383-96) are disclosed, but the production cost is very high or the yield is very low due to the use of metal such as platinum or high pressure reaction.

이에 본 발명자는 상기와 같은 종래의 제조방법상의 문제점을 해결하기 위해 노력한 결과 종래에 비해 좋은 특징과 장점을 갖는 본 발명을 완성하게 되었다.Accordingly, the present inventors have endeavored to solve the problems of the conventional manufacturing method as described above, and have completed the present invention having better features and advantages than the conventional one.

본 발명의 목적은 천연에 풍부하게 존재하는 매우 저렴한 광학활성 α-아미노산인 L-글루타민산 및 L-아디픽산과 그들의 광학이성질체들을 이용하여 4단계의 짧은 합성경로를 거쳐 광학활성이 있는 3-아미노 헤테로고리아민 유도체들을 매우 안전한 조건에서 합성하므로써, 상기 언급한 공지의 제조방법들이 가지고 있는 문제점들을 해결할 수 있는 새로운 제조방법을 제공하는데 있다.An object of the present invention is to provide optically active 3-amino hetero via four short synthetic routes using L-glutamic acid and L-adipic acid and their optical isomers, which are very inexpensive optically active α-amino acids present in nature By synthesizing cyclic amine derivatives in a very safe condition, it is to provide a new production method that can solve the problems of the known production methods mentioned above.

본 발명의 요지는 천연중에 풍부하게 존재하는 매우 저렴한 광학활성 α-아미노산인 L-글루타민산 및 L-아디픽산과 그들의 광학이설질체들을 출발물질로 하여, 먼저 선택적 보호방법에 의해 아미노기와 카르복실기를 보호하여 일반식(II)의 아미노산 유도체를 합성하고,The gist of the present invention is a very inexpensive optically active α-amino acid, L-glutamic acid and L-adipic acid and their optical isomers, which are abundant in nature. To synthesize an amino acid derivative of formula (II),

카르복실기의 선택적인 환원에 의해 광학활성이 있는 일반식(III)의 2-아미노-알칸디올 유도체를 제조하고,By selective reduction of the carboxyl group to prepare a 2-amino-alkanediol derivative of the general formula (III) having optical activity,

일반식(III)의 디올 화합물을 친핵성 치환반응이 잘 일어날 수 있는 보호기로 보호시켜 일반식(IV)의 화합물로 변화시키고,The diol compound of general formula (III) is protected by a protecting group which can easily undergo a nucleophilic substitution reaction, thereby changing to a compound of general formula (IV),

일반식(IV)의 보호된 2-아미노-알칸디올의 술포닐 유도체를 아민 유도체와 반응시켜 광학활성이 있는 보호된 일반식(I)의 3-아미노 헤테로고리아민 유도체를 제조하는 방법에 관한 것이다.A method of preparing a 3-amino heterocyclic amine derivative of protected general formula (I) which is optically active by reacting a sulfonyl derivative of protected 2-amino-alkanediol of formula (IV) with an amine derivative .

상기식에서, n은 1 또는 2, R1은 탄소수 1-6의 저급 알킬, R2은 수소 또는 탄소수 1-6의 저급 알킬, R3은 저급 알킬, 벤질옥시카르보닐, 특히 t-부틸옥시카르보닐, R4는 톨루엔기 또는 메틸을 나타내며, R5는 수소 또는 벤질, (R)-또는 (S)-페닐에틸, 벤즈히드릴기를 나타낸다.Wherein n is 1 or 2, R 1 is lower alkyl of 1-6 carbon atoms, R 2 is hydrogen or lower alkyl of 1-6 carbon atoms, R 3 is lower alkyl, benzyloxycarbonyl, in particular t-butyloxycarbon Bonyl, R 4 represents a toluene group or methyl, R 5 represents hydrogen or benzyl, (R)-or (S) -phenylethyl, benzhydryl group.

본 발명은 천연에 존재하는 α-아미노산인 L-글루타민산 및 L-아디픽산과 그들의 광학이성질체를 출발물질로 하여, 일반적인 에스테르화반응인 산촉매하에서 메틸알콜 또는 에틸알콜등과 반응하여 알킬에스테르 유도체를 얻고, 분리없이 벤질옥시카보닐 클로라이드 또는 디 t-부틸옥시카보닐을 트리에틸아민 또는 소디움히드록시드등의 염기 존재하에서 반응시켜 일반식(II)의 선택적으로 보호된 아미노산 유도체를 얻고, 이 아미노산 유도체를 칼슐클로라이드 존재하의 에틸 알콜 용매하에서 소디움보로히드라이드에 의해 일반식(III)의 2-아미노-알칸디올을 제조한 후, 일반식(III)의 화합물을 염기존재하의 메틸렌클로라이드 용매에서 톨루엔술포닐클로라이드 또는 메탄술포닐클로라이드와 반응시켜 2-아미노-1,4-부탄디올의 술포닐치환체인 일반식(IV)의 화합물을 제조한후, 일반식(IV)의 화합물을 1차 아민류 또는 암모니아수와 소디움카보네이트 존재하의 아세토니트릴 또는 메틸렌클로라이드 용매하에서 반응시켜 치환된 일반식(I)의 3-아미노 헤테로고리아민 유도체들을 제조하는 방법이다.The present invention starts from the natural α-amino acid L- glutamic acid and L- adipic acid and their optical isomers as starting materials, to obtain alkyl ester derivatives by reaction with methyl alcohol or ethyl alcohol under an acid catalyst which is a general esterification reaction. Without reaction, benzyloxycarbonyl chloride or di-butyloxycarbonyl is reacted in the presence of a base such as triethylamine or sodium hydroxide to obtain an optionally protected amino acid derivative of the general formula (II). 2-amino-alkanediol of formula (III) was prepared by sodium borohydride in ethyl alcohol solvent in the presence of a chloride chloride, and then the compound of formula (III) was dissolved in a methylene chloride solvent in the presence of a base. General formula (IV) which is a sulfonyl substituent of 2-amino-1,4-butanediol by reacting with polyphenyl or methanesulfonyl chloride Compounds of Formula (IV) were reacted with primary amines or aqueous ammonia and acetonitrile or methylene chloride in the presence of sodium carbonate to prepare the substituted 3-amino heterocyclic amine derivatives of Formula (I). It is a method of manufacturing.

본 발명의 반응절차를 반응식으로 표시하면 다음과 같다.When the reaction procedure of the present invention is represented by the reaction scheme as follows.

상기식에서, n은 1 또는 2, R1은 탄소수 1-6의 저급 알킬, R2은 수소 또는 탄소수 1-6의 저급 알킬, R3은 탄소수 1-6의 저급 알킬, 벤질옥시카르보닐, 특히 t-부틸옥시카르보닐, R4는 톨루엔기 또는 메틸을 나타내며, R5는 수소 또는 벤질, (R)-또는 (S)-페닐에틸, 벤즈히드릴기를 나타낸다.Wherein n is 1 or 2, R 1 is lower alkyl of 1-6 carbon atoms, R 2 is hydrogen or lower alkyl of 1-6 carbon atoms, R 3 is lower alkyl of 1-6 carbon atoms, benzyloxycarbonyl, in particular t-butyloxycarbonyl, R 4 represents a toluene group or methyl, and R 5 represents hydrogen or benzyl, (R)-or (S) -phenylethyl, benzhydryl group.

본 발명의 단계 1은 L- 또는 D- 형태의 글루타민산 및 아디픽산등의 카르복실기를 일반적인 방법인 에스테르화에 의해 메틸에스테르 또는 에틸에스테르를 합성하고, 분리과정 없이 아민기를 디 t-부틸옥시카르보닐 또는 벤질옥시카르보닐 클로라이드와 트리에틸아민 등의 염기조건과 테트라히드로푸란 용매 또는 디옥산-증류수용매에서 아미노기를 보호하였다. 단계 1에 적용될 수 있는 R1, R2, R3는 각각 상기에서 기술한 바가 있으며, 특히 R1은 메틸 또는 에틸일 때 수율이 양호하며 R2는 수소, 메틸 또는 에틸일 때 그리고 R3는 t-부틸옥시카르보닐일때 양호한 결과를 얻었다.Step 1 of the present invention synthesizes methyl ester or ethyl ester by esterification which is a common method of carboxyl groups such as glutamic acid and adipic acid in L- or D- form, and the amine group is separated by di-butyloxycarbonyl or The amino groups were protected in basic conditions such as benzyloxycarbonyl chloride and triethylamine and in tetrahydrofuran solvent or dioxane-distilled solvent. R 1 , R 2 and R 3 which can be applied to step 1 have been described above, in particular, when R 1 is methyl or ethyl, the yield is good, when R 2 is hydrogen, methyl or ethyl and R 3 is Good results were obtained with t-butyloxycarbonyl.

본 발명의 단계 2는 에스테르를 환원하여 알콜을 제조하는 단계로써, 리튬-알루미늄히드라이드 또는 소듐보로히드라이드에 칼슘클로라이드 등을 첨가하므로써 높은 수율과 빠른 반응을 나타내었다. 리튬알루미늄히드라이드 조건에서는 용매로써 테트라히드로푸란을 사용할 수 있으며, 소듐보로히드라이드 조건에서는 메틸알콜, 에틸알콜, 이소프로필알콜 등의 저급알코올을 용매로 사용할 수 있다. 반응온도는 상온에서도 매우 빠른 속도를 나타내거나, 0℃로 냉각하여 반응하는 것이 바람직하다.Step 2 of the present invention is a step of reducing the ester to prepare an alcohol, showing a high yield and fast reaction by adding calcium chloride and the like to lithium-aluminum hydride or sodium borohydride. Tetrahydrofuran may be used as a solvent under lithium aluminum hydride conditions, and lower alcohols such as methyl alcohol, ethyl alcohol and isopropyl alcohol may be used as a solvent under sodium borohydride conditions. The reaction temperature is very fast even at room temperature, or cooled to 0 ℃ it is preferable to react.

본 발명의 단계 3은 구조식(III)의 디올 유도체를 술포닐화합물로 변화시키는 단계로써, 알킬술포닐클로라이드 또는 아릴술포닐클로라이드 등을 2.5에서 5당량을 사용하며, 용매로는 메틸렌클로라이드 등의 불활성 용매를 이용하는 것이 바람직하다. 이때 사용되는 염기로는 트리에틸아민, 피리딘 등의 유기염기가 이용되며 3당량에서 5당량을 이용할 수 있다.Step 3 of the present invention is a step of converting the diol derivative of formula (III) into a sulfonyl compound, using 2.5 to 5 equivalents of alkylsulfonyl chloride or arylsulfonyl chloride and the like, and inert solvent such as methylene chloride. It is preferable to use a solvent. At this time, organic bases such as triethylamine and pyridine may be used as the base, and 3 equivalents to 5 equivalents may be used.

본 발명의 단계 4는 시클로화반응으로써 구조식(I)의 3-아미노 헤테로고리아민유도체의 제조를 나타내며, 시클로화반응의 아민들은 암모늄클로라이드, 암모늄카보네이트, 암모늄히드록시드, 벤질아민, 페닐에틸아민, 디페닐메틸아민 등이 이용되며 아민의 종류에 따라 다른 수율을 나타낸다. 이때 이용되는 염기는 암모니아, 포타슘카보네이트 또는 소디움카보네이트가 있으며, 사용되는 용매로는 물, 메탄올, 아세토니트릴 또는 디클로로메탄 등이 단독 또는 혼합액으로 유용하게 사용된다. 반응온도는 상온에서도 좋은 수율을 나타내거나, 50℃ 정도 가열해서 높은 수율로 일반식(I)의 3-아미노 헤테로고리아민유도체들을 얻을 수 있다.Step 4 of the present invention shows the preparation of 3-amino heterocyclic amine derivative of formula (I) by cyclolation reaction, wherein the amines of cyclolation reaction are ammonium chloride, ammonium carbonate, ammonium hydroxide, benzylamine, phenylethylamine , Diphenylmethylamine and the like are used and show different yields depending on the type of amine. At this time, the base used is ammonia, potassium carbonate or sodium carbonate, and the solvent used is water, methanol, acetonitrile or dichloromethane or the like is usefully used alone or as a mixed solution. The reaction temperature shows a good yield even at room temperature, or can be heated to about 50 ℃ to obtain 3-amino heterocyclic amine derivatives of the general formula (I) in a high yield.

본 발명은 기존의 방법들과 비교해 볼 때 다음과 같은 특징과 장점이 있다. 첫째 : 값싸고 풍부한 α-아미노산들과 그의 광학이성질체를 출발물질로하여 짧은 제조과정을 거쳐 목적화합물인 일반식(I)의 3-아미노 헤테로고리아민유도체들을 수득하므로써 매우 경제적인 방법을 개발했으며, 둘째 : 출발물질의 광학활성이 그대로 유지되어 목적화합물의 광학활성을 나타내므로써 기존의 제조방법들에 비해 더욱 순수한 키랄화합물을 합성할 수 있으며, 셋째 : 경우에 따라서 금속화합물이 이용되지 않으므로써 우수한 경제성 또는 환경오염을 줄이는데 그 특징이 있다.The present invention has the following features and advantages compared to the existing methods. Firstly, we developed a very economical method by obtaining 3-amino heterocyclic amine derivatives of general formula (I) through a short manufacturing process starting from cheap and abundant α-amino acids and their optical isomers. Second: Since the optical activity of the starting material is maintained as it is, it shows the optical activity of the target compound, and thus, more pure chiral compounds can be synthesized than the conventional methods. Or to reduce environmental pollution.

이하 본 발명을 실시예에 의거하여 더 구체적으로 설명하면 다음과 같으며, 본 발명이 반드시 다음의 실시예에만 국한된 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. The present invention is not necessarily limited to the following Examples.

[실시예 1]Example 1

(L)-(-)-N-t-부틸옥시카르보닐글루타민산 디메틸에스테르의 제조Preparation of (L)-(-)-N-t-butyloxycarbonylglutamic acid dimethyl ester

(L)-글루타민산(0.1 mol)을 무수메틸알콜(100 ml)에 현탁시킨후 진한황산(10ml)을 적가하고 18시간동안 환류 교반한다. 이 용액을 감압하에서 농축한 다음 얻어진 잔사를 물:디옥산(1:1, 100 ml)에 녹이고 0-5℃로 냉각한후 트리에틸아민(0.5 mol)을 적가시킨 다음, 동온도에서 5분간 교반한다. 이 용액에 동 온도에서 디-t-부틸옥시카르보닐(0.13 mol)을 물:디옥산(1:1, 50 ml)에 녹인 용액을 적가한 후 실온에서 3시간동안 교반한다. 반응완결 후 감압하에서 유기용매를 제거한 다음 디클로로메탄으로 추출(100 ml x 2)하고 포화식염수로 세척한 후 마그네슘설페이트로 건조하고 감압하에서 유기용매를 제거하면 (L)-(-)-N-t-부틸옥시카르보닐글루타민산 디메틸에스테르가 얻어진다.(L) -Glutamic acid (0.1 mol) is suspended in methyl alcohol anhydride (100 ml), followed by dropwise addition of concentrated sulfuric acid (10 ml) and stirring under reflux for 18 hours. The solution was concentrated under reduced pressure, and the obtained residue was dissolved in water: dioxane (1: 1, 100 ml), cooled to 0-5 ° C, and triethylamine (0.5 mol) was added dropwise, followed by 5 minutes at the same temperature. Stir. To this solution was added dropwise a solution of di-t-butyloxycarbonyl (0.13 mol) in water: dioxane (1: 1, 50 ml) at the same temperature, followed by stirring at room temperature for 3 hours. After completion of the reaction, the organic solvent was removed under reduced pressure, extracted with dichloromethane (100 ml x 2), washed with saturated brine, dried over magnesium sulfate, and the organic solvent was removed under reduced pressure (L)-(-)-Nt-butyl. Oxycarbonyl glutamic acid dimethyl ester is obtained.

[실시예 2]Example 2

(L)-(-)-N-t-부틸옥시카르보닐아디픽산 디메틸에스테르의 제조Preparation of (L)-(-)-N-t-butyloxycarbonyladipic acid dimethyl ester

(L)-아디픽산(0.1 mol)을 무수메틸알콜(100 ml)에 현탁시킨후 진한황산(10ml)을 적가하고 18시간동안 환류 교반한다. 이 용액을 감압하에서 농축한 다음 얻어진 잔사를 물:디옥산(1:1, 100 ml)에 녹이고 0-5℃로 냉각한후 트리에틸아민(0.5 mol)을 적가시킨 다음, 동온도에서 5분간 교반한다. 이 용액에 동 온도에서 디-t-부틸옥시카르보닐(0.13 mol)을 물:디옥산(1:1, 50 ml)에 녹인 용액을 적가한 후 실온에서 3시간동안 교반한다. 반응완결 후 감압하에서 유기용매를 제거한 다음 디클로로메탄으로 추출(100 ml x 2)하고 포화식염수로 세척한 후 마그네슘설페이트로 건조하고 감압하에서 유기용매를 제거하면 (L)-(-)-N)t-부틸옥시카르보닐글루타민산 디메틸에스테르가 얻어진다.(L) -adipic acid (0.1 mol) is suspended in methyl alcohol anhydride (100 ml), and then concentrated sulfuric acid (10 ml) is added dropwise and stirred under reflux for 18 hours. The solution was concentrated under reduced pressure, and the obtained residue was dissolved in water: dioxane (1: 1, 100 ml), cooled to 0-5 ° C, and triethylamine (0.5 mol) was added dropwise, followed by 5 minutes at the same temperature. Stir. To this solution was added dropwise a solution of di-t-butyloxycarbonyl (0.13 mol) in water: dioxane (1: 1, 50 ml) at the same temperature, followed by stirring at room temperature for 3 hours. After completion of the reaction, the organic solvent was removed under reduced pressure, extracted with dichloromethane (100 ml x 2), washed with brine, dried over magnesium sulfate, and the organic solvent was removed under reduced pressure (L)-(-)-N) t. -Butyl oxycarbonyl glutamic acid dimethyl ester is obtained.

[실시예 3]Example 3

(D)-(+)-N-t-부틸옥시카르보닐글루타민산 디메틸에스테르의 제조Preparation of (D)-(+)-N-t-butyloxycarbonylglutamic acid dimethyl ester

D-형태의 α-글루타민산을 이용하여 실시예 2와 같은 방법에 의해 D-(+)-N-t-부틸옥시카르보닐 글루타민산 디메틸에스테르가 얻어진다.D-(+)-N-t-butyloxycarbonyl glutamic acid dimethyl ester is obtained by the same method as in Example 2 using D-form α-glutamic acid.

[실시예 4]Example 4

(D)-(+)-N-t-부틸옥시카르보닐아디픽산 디메틸에스테르의 제조Preparation of (D)-(+)-N-t-butyloxycarbonyladipic acid dimethyl ester

D-형태의 α-아디픽산을 이용하여 실시예 2와 같은 방법에 의해 D-(+)-N-t-부틸옥시카르보닐 아디픽산 디메틸에스테르가 얻어진다.D-(+)-N-t-butyloxycarbonyl adipic acid dimethyl ester is obtained by the same method as in Example 2 using D-form α-adipic acid.

[실시예 5]Example 5

(L)-(-)-N-t-부틸옥시카르보닐-N-메틸글루타민산 디메틸에스테르의 제조Preparation of (L)-(-)-N-t-butyloxycarbonyl-N-methylglutamic acid dimethyl ester

(L)-(-)-N-t-부틸옥시카르보닐 글루타민산 디메틸에스테르 1당량을 무수의 테트라히드로푸란 용액에 녹이고 소디움히드라이드 1.1당량을 가한 다음 이 용액에 메틸아이오다이드를 1.5당량 가한 후 상온에서 교반한다. 반응후 소디움히드로겐카보네이트 용액으로 추출한 다음 유기층은 무수마그네슘설페이트로 건조하고 감압하에서 용매를 제거하여 생성물을 얻었다. 고체는 다음의 반응에 그대로 사용할 수 있으며, 필요에 따라서 재결정하여 L-(-)-N-t-부틸옥시카르보닐-N-메틸글루타민산 디메틸에스테르가 얻어진다.1 equivalent of (L)-(-)-Nt-butyloxycarbonyl glutamic acid dimethyl ester is dissolved in anhydrous tetrahydrofuran solution, 1.1 equivalent of sodium hydride is added, and then 1.5 equivalent of methyl iodide is added to the solution at room temperature. Stir. After the reaction, the mixture was extracted with sodium hydrogencarbonate solution, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure to obtain a product. The solid can be used as it is for the following reaction, and recrystallized as necessary to give L-(-)-N-t-butyloxycarbonyl-N-methylglutamic acid dimethyl ester.

[실시예 6]Example 6

(L)-(-)-N-t-부틸옥시카르보닐-N-메틸아디픽산 디메틸에스테르의 제조Preparation of (L)-(-)-N-t-butyloxycarbonyl-N-methyladipic acid dimethyl ester

(L)-(-)-N-t-부틸옥시카르보닐 아디픽산 디메틸에스테르 1당량을 무수의 테트라히드로푸란 용액에 녹이고 소디움히드라이드 1.1당량을 가한 다음 이 용액에 메틸아이오다이드를 1.5당량 가한 후 상온에서 교반한다. 반응후 소디움히드로겐카보네이트 용액으로 추출한 다음 유기층은 무수마그네슘설페이트로 건조하고 감압하에서 용매를 제거하여 생성물을 얻었다. 고체는 다음의 반응에 그대로 사용할 수 있으며, 필요에 따라서 재결정하여 L-(-)-N-t-부틸옥시카르보닐-N-메틸글루타민산 디메틸에스테르가 얻어진다.Dissolve 1 equivalent of (L)-(-)-Nt-butyloxycarbonyl adipic acid dimethyl ester in anhydrous tetrahydrofuran solution, add 1.1 equivalent of sodium hydride, add 1.5 equivalents of methyl iodide to this solution, and then room temperature Stir in After the reaction, the mixture was extracted with sodium hydrogencarbonate solution, the organic layer was dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure to obtain a product. The solid can be used as it is for the following reaction, and recrystallized as necessary to give L-(-)-N-t-butyloxycarbonyl-N-methylglutamic acid dimethyl ester.

[실시예 7]Example 7

S-(-)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올의 제조Preparation of S-(-)-2-t-butyloxycarbonylamino-1,5-pentanediol

무수 에틸알콜에 칼슘클로라이드 분말 2∼4당량을 분산시키고 0℃로 냉각한 후 소디움보로히드리드 3∼5당량을 가한 다음 동 온도에서 1시간동안 교반한다. 이 용액에 N-보호된 글루타민산 디메틸에스테르 1당량을 무수 에틸알콜에 녹인 용액을 동 온도에서 적가한 후 1시간동안 교반한 다음 실온에서 3시간동안 교반한다. 과량의 물을 가한 후 감압하에서 유기용매를 제거하고 염화나트륨으로 포화 시킨후 에틸아세테이트로 추출하고 무수 마그네슘설페이트로 건조한 다음 감압하에서 농축하면 흰색고체가 얻어진다. 얻어진 흰색고체를 소량의 디클로로메탄에 녹인후 0℃에서 n-헥산을 가하고 동 온도에서 1시간동안 교반하고 생성된 흰색고체를 여과한 후 감압하에서 건조하면 순수한 흰색고체의 S-(-)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올이 얻어진다.2-4 equivalents of calcium chloride powder was dispersed in anhydrous ethyl alcohol, cooled to 0 ° C., and then 3-5 equivalents of sodium borohydride were added and stirred at the same temperature for 1 hour. A solution of 1 equivalent of N-protected glutamic acid dimethyl ester in anhydrous ethyl alcohol was added dropwise at the same temperature, followed by stirring for 1 hour, followed by stirring at room temperature for 3 hours. After adding excess water, the organic solvent was removed under reduced pressure, saturated with sodium chloride, extracted with ethyl acetate, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give a white solid. The obtained white solid was dissolved in a small amount of dichloromethane, n-hexane was added at 0 ° C., stirred for 1 hour at the same temperature, the produced white solid was filtered and dried under reduced pressure to obtain pure white solid S-(-)-2. -t-butyloxycarbonylamino-1,5-pentanediol is obtained.

[실시예 8]Example 8

S-(-)-2-t-부틸옥시카르보닐아미노-1,6-헥산디올의 제조Preparation of S-(-)-2-t-butyloxycarbonylamino-1,6-hexanediol

무수 에틸알콜에 칼슘클로라이드 분말 2∼4당량을 분산시키고 0℃로 냉각한 후 소디움보로히드리드 3∼5당량을 가한 다음 동 온도에서 1시간동안 교반한다. 이 용액에 N-보호된 아디픽산 디메틸에스테르 1당량을 무수 에틸알콜에 녹인 용액을 동 온도에서 적가한 후 1시간동안 교반한 다음 실온에서 3시간동안 교반한다. 과량의 물을 가한 후 감압하에서 유기용매를 제거하고 염화나트륨으로 포화 시킨후 에틸아세테이트로 추출하고 무수 마그네슘설페이트로 건조한 다음 감압하에서 농축하면 흰색고체가 얻어진다. 얻어진 흰색고체를 소량의 디클로로메탄에 녹인후 0℃에서 n-헥산을 가하고 동 온도에서 1시간동안 교반하고 생성된 흰색고체를 여과한 후 감압하에서 건조하면 순수한 흰색고체의 S-(-)-2-t-부틸옥시카르보닐아미노-1,6-헥산디올이 얻어진다.2-4 equivalents of calcium chloride powder was dispersed in anhydrous ethyl alcohol, cooled to 0 ° C., and then 3-5 equivalents of sodium borohydride were added and stirred at the same temperature for 1 hour. A solution of 1 equivalent of N-protected adipic acid dimethyl ester in anhydrous ethyl alcohol was added dropwise at the same temperature, followed by stirring for 1 hour, followed by stirring at room temperature for 3 hours. After adding excess water, the organic solvent was removed under reduced pressure, saturated with sodium chloride, extracted with ethyl acetate, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give a white solid. The obtained white solid was dissolved in a small amount of dichloromethane, n-hexane was added at 0 ° C., stirred for 1 hour at the same temperature, the produced white solid was filtered and dried under reduced pressure to obtain pure white solid S-(-)-2. -t-butyloxycarbonylamino-1,6-hexanediol is obtained.

[실시예 9]Example 9

R-(+)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올의 제조Preparation of R-(+)-2-t-butyloxycarbonylamino-1,5-pentanediol

D-(+)-N-t-부틸옥시카르보닐 글루타민산 디메틸에스테르를 이용하여 실시예 7과 같은 방법에 의해 R-(+)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올이 얻어진다.R-(+)-2-t-butyloxycarbonylamino-1,5-pentanediol was obtained by the same method as Example 7 using D-(+)-Nt-butyloxycarbonyl glutamic acid dimethyl ester. Lose.

[실시예 10]Example 10

R-(+)-2-t-부틸옥시카르보닐아미노-1,6-헥산디올의 제조Preparation of R-(+)-2-t-butyloxycarbonylamino-1,6-hexanediol

D-(+)-N-t-부틸옥시카르보닐 아디픽산 디메틸에스테르를 이용하여 실시예 8과 같은 방법에 의해 R-(+)-2-t-부틸옥시카르보닐아미노-1,6-헥산디올이 얻어진다.R-(+)-2-t-butyloxycarbonylamino-1,6-hexanediol was prepared by the same method as in Example 8 using D-(+)-Nt-butyloxycarbonyl adipic acid dimethyl ester. Obtained.

[실시예 11]Example 11

S-(-)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올의 제조Preparation of S-(-)-2-t-butyloxycarbonylamino-1,5-pentanediol

L-(-)-N-t-부틸옥시카르보닐-N-메틸글루타민산 디메틸에스테르를 이용하여 실시예 7과 같은 방법에 의해 S-(-)-2-t-부틸옥시카르보닐아미노-1,5-펜탄디올이 얻어진다.S-(-)-2-t-butyloxycarbonylamino-1,5- by the same method as in Example 7 using L-(-)-Nt-butyloxycarbonyl-N-methylglutamic acid dimethyl ester Pentanediol is obtained.

[실시예 12]Example 12

S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,6-헥산디올의 제조Preparation of S-(-)-2-t-butyloxycarbonylmethylamino-1,6-hexanediol

L-(-)-N-t-부틸옥시카르보닐-N-메틸아디픽산 디메틸에스테르를 이용하여 실시예 8과 같은 방법에 의해 S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,6-헥산디올이 얻어진다.S-(-)-2-t-butyloxycarbonylmethylamino-1, by the same method as in Example 8 using L-(-)-Nt-butyloxycarbonyl-N-methyladipic acid dimethyl ester 6-hexanediol is obtained.

[실시예 13]Example 13

S-(-)-2-t-부틸옥시카르보닐아미노-1,5-디메탄술폰옥시-펜탄의 제조Preparation of S-(-)-2-t-butyloxycarbonylamino-1,5-dimethanesulfonoxy-pentane

N-보호된 1.5-펜탄디올 1당량을 메틸렌클로라이드에 녹이고 -10℃ - 0℃로 냉각한 다음 트리에틸아민 3당량을 적가한 후 동 온도에서 5분동안 교반한다. 이 용액에 메탄술포닐클로라이드 2.5당량을 가한 후 동 온도에서 1시간 동안 교반한다. 반응완결 후 포화된 소디움히드로겐카보네이트 수용액, 물, 포화된 소디움 클로라이드 순으로 세척한 후, 무수 마그네슘설페이트로 건조한 다음 감압하에서 농축하면 약간 노란색의 고체가 얻어진다. 얻어진 고체를 다시 소량의 메틸렌클로라이드에 녹이고 0℃에서 헥산을 가한 후 동 온도에서 1시간동안 교반한다. 생성된 흰색고체를 여과한 후 감압건조하면 순수한 희색고체의 S-(-)-2-t-부틸옥시카르보닐아미노-1,5-디메탄술폰옥시-펜탄이 얻어진다.1 equivalent of N-protected 1.5-pentanediol is dissolved in methylene chloride, cooled to -10 ° C-0 ° C, and then 3 equivalents of triethylamine are added dropwise and stirred at the same temperature for 5 minutes. 2.5 equivalents of methanesulfonyl chloride was added to the solution, followed by stirring at the same temperature for 1 hour. After completion of the reaction, the resultant was washed with saturated aqueous sodium hydrogencarbonate solution, water and saturated sodium chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give a slightly yellow solid. The obtained solid is again dissolved in a small amount of methylene chloride, hexane is added at 0 ° C., and then stirred at the same temperature for 1 hour. The resulting white solid was filtered and dried under reduced pressure to obtain pure white solid S-(-)-2-t-butyloxycarbonylamino-1,5-dimethanesulfonoxy-pentane.

[실시예 14]Example 14

S-(-)-2-t-부틸옥시카르보닐아미노-1,6-디메탄술폰옥시-헥산의 제조Preparation of S-(-)-2-t-butyloxycarbonylamino-1,6-dimethanesulfonoxy-hexane

N-보호된 1.6-헥산디올 1당량을 메틸렌클로라이드에 녹이고 -10℃ - 0℃로 냉각한 다음 트리에틸아민 3당량을 적가한 후 동 온도에서 5분동안 교반한다. 이 용액에 메탄술포닐클로라이드 2.5당량을 가한 후 동 온도에서 1시간 동안 교반한다. 반응완결 후 포화된 소디움히드로겐카보네이트 수용액, 물, 포화된 소디움 클로라이드 순으로 세척한 후, 무수 마그네슘설페이트로 건조한 다음 감압하에서 농축하면 약간 노란색의 고체가 얻어진다. 얻어진 고체를 다시 소량의 메틸렌클로라이드에 녹이고 0℃에서 헥산을 가한 후 동 온도에서 1시간동안 교반한다. 생성된 흰색고체를 여과한 후 감압건조하면 순수한 흰색고체의 S-(-)-2-t-부틸옥시카르보닐아미노-1,6-디메탄술폰옥시-헥산이 얻어진다.1 equivalent of N-protected 1.6-hexanediol is dissolved in methylene chloride, cooled to -10 ° C-0 ° C, and then 3 equivalents of triethylamine are added dropwise and stirred at the same temperature for 5 minutes. 2.5 equivalents of methanesulfonyl chloride was added to the solution, followed by stirring at the same temperature for 1 hour. After completion of the reaction, the resultant was washed with saturated aqueous sodium hydrogencarbonate solution, water and saturated sodium chloride, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give a slightly yellow solid. The obtained solid is again dissolved in a small amount of methylene chloride, hexane is added at 0 ° C., and then stirred at the same temperature for 1 hour. The resulting white solid was filtered and dried under reduced pressure to obtain pure white solid S-(-)-2-t-butyloxycarbonylamino-1,6-dimethanesulfonoxy-hexane.

[실시예 15]Example 15

R-(+)-2-t-부틸옥시카르보닐아미노-1,5-디메탄술폰옥시-펜탄의 제조Preparation of R-(+)-2-t-butyloxycarbonylamino-1,5-dimethanesulfonoxy-pentane

R-(+)-2-t-부틸옥시카르보닐아미노-펜탄디올을 이용하여 실시예 13과 같은 방법에 의해 R-(+)-2-t-부틸옥시카르보닐아미노-1,5-디메탄술폰옥시-펜탄이 얻어진다.R-(+)-2-t-butyloxycarbonylamino-1,5-di by the same method as in Example 13 using R-(+)-2-t-butyloxycarbonylamino-pentanediol Methanesulfonoxy-pentane is obtained.

[실시예 16]Example 16

R-(+)-2-t-부틸옥시카르보닐아미노-1,6-디메탄술폰옥시-헥산의 제조Preparation of R-(+)-2-t-butyloxycarbonylamino-1,6-dimethanesulfonoxy-hexane

R-(+)-2-t-부틸옥시카르보닐아미노-헥산디올을 이용하여 실시예 14와 같은 방법에 의해 R-(+)-2-t-부틸옥시카르보닐아미노-1,6-디메탄술폰옥시-헥산이 얻어진다.R-(+)-2-t-butyloxycarbonylamino-1,6-di by the same method as in Example 14 using R-(+)-2-t-butyloxycarbonylamino-hexanediol Methanesulfoneoxy-hexane is obtained.

[실시예 17]Example 17

S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,5-디메탄술폰옥시-펜탄의 제조Preparation of S-(-)-2-t-butyloxycarbonylmethylamino-1,5-dimethanesulfonoxy-pentane

S-(-)-2-t-부틸옥시카르보닐메틸아미노-펜탄디올을 이용하여 실시예 13과 같은 방법에 의해 S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,5-디메탄술폰옥시-펜탄이 얻어진다.S-(-)-2-t-butyloxycarbonylmethylamino-1,5 by the same method as Example 13 using S-(-)-2-t-butyloxycarbonylmethylamino-pentanediol -Dimethanesulfonoxy-pentane is obtained.

[실시예 18]Example 18

S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,6-디메탄술폰옥시-헥산의 제조Preparation of S-(-)-2-t-butyloxycarbonylmethylamino-1,6-dimethanesulfonoxy-hexane

S-(-)-2-t-부틸옥시카르보닐메틸아미노--헥산디올을 이용하여 실시예 14와 같은 방법에 의해 S-(-)-2-t-부틸옥시카르보닐메틸아미노-1,6-디메탄술폰옥시-헥산이 얻어진다.S-(-)-2-t-butyloxycarbonylmethylamino-1, S-(-)-2-t-butyloxycarbonylmethylamino-1, by the same method as in Example 14 using hexanediol 6-dimethanesulfoneoxy-hexane is obtained.

[실시예 19]Example 19

S-(-)-3-t-부틸옥시카르보닐아미노피페리딘의 제조Preparation of S-(-)-3-t-butyloxycarbonylaminopiperidine

디메탄술폰옥시 펜탄 유도체 1당량을 암모니아수(28%):아세토니트릴(1:1)에 녹인후 반응하거나 소디움카보네이트 또는 포타슘카보네이트 1∼3당량을 넣은 다음 실온에서 2-3일 동안 교반한다. 이 반응혼합물을 여과한 후 유기층을 분리하고 수층은 클로로포름으로 추출한다. 추출액과 유기층을 합체 무수포타슘카보네이트로 건조한 후 감압하에서 용매를 제거하여, 또는 히드로클로라이드와의 염을 형성시켜 결정을 얻은 후 히드로클로라이드를 제거하여 S-(-)-t-부틸옥시카르보닐아미노피페리딘을 얻었다.One equivalent of dimethanesulfonoxy pentane derivative is dissolved in ammonia water (28%): acetonitrile (1: 1) and then reacted, or 1 to 3 equivalents of sodium carbonate or potassium carbonate are added and stirred at room temperature for 2-3 days. The reaction mixture was filtered and the organic layer was separated and the aqueous layer was extracted with chloroform. The extract and the organic layer were dried over a mixture of anhydrous potassium carbonate, and then the solvent was removed under reduced pressure, or a salt was formed with a hydrochloride to obtain crystals. The hydrochloride was removed to remove S-(-)-t-butyloxycarbonylaminopi. Got ferridine.

[실시예 20]Example 20

S-(-)-3-t-부틸옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H 아제핀의 제조Preparation of S-(-)-3-t-butyloxycarbonylamino-2,3,4,5,6,7-hexahydro-1H azepine

디메탄술폰옥시 펜탄 유도체 1당량을 암모니아수(28%):아세토니트릴(1:1)에 녹인후 반응하거나 소디움카보네이트 또는 포타슘카보네이트 1∼3당량을 넣은 다음 30-35℃에서 2-3일 동안 교반한다. 이 반응혼합물을 여과한 후 유기층을 분리하고 수층은 클로로포름으로 추출한다. 추출액과 유기층을 합쳐 무수포타슘카보네이트로 건조한 후 감압하에서 용매를 제거하여, 또는 히드로클로라이드와의 염을 형성시켜 결정을 얻은 후 히드로클로라이드를 제거하여 S-(-)-t-부틸옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀을 얻었다.1 equivalent of dimethanesulfonoxy pentane derivative is dissolved in ammonia water (28%): acetonitrile (1: 1) and then reacted or 1 to 3 equivalents of sodium carbonate or potassium carbonate are stirred at 30-35 ° C. for 2-3 days. do. The reaction mixture was filtered and the organic layer was separated and the aqueous layer was extracted with chloroform. Combine the extract with the organic layer, dry over anhydrous potassium carbonate, remove the solvent under reduced pressure, or form a salt with hydrochloride to obtain crystals. Remove hydrochloride to remove S-(-)-t-butyloxycarbonylamino- 2,3,4,5,6,7-hexahydro-1H-azepine was obtained.

[실시예 21]Example 21

R-(+)-3-t-부틸옥시카르보닐아미노 피페리딘의 제조Preparation of R-(+)-3-t-butyloxycarbonylamino piperidine

R-(+)-2-t-부틸옥시카르보닐아미노-디메탄술폰옥시펜탄을 이용하여 실시예 19과 같은 방법에 의해 R-(+)-3-t-부틸옥시카르보닐아미노 피페리딘이 얻어진다.R-(+)-3-t-butyloxycarbonylamino piperidine by the same method as in Example 19 using R-(+)-2-t-butyloxycarbonylamino-dimethanesulfonoxypentane Is obtained.

[실시예 22]Example 22

R-(+)-3-t-부틸옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀의 제조Preparation of R-(+)-3-t-butyloxycarbonylamino-2,3,4,5,6,7-hexahydro-1H-azepine

R-(+)-2-t-부틸옥시카르보닐아미노-디메탄술폰옥시헥산을 이용하여 실시예 20과 같은 방법에 의해 R-(+)-3-t-부틸옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀이 얻어진다.R-(+)-3-t-butyloxycarbonylamino-2, by the same method as in Example 20 using R-(+)-2-t-butyloxycarbonylamino-dimethanesulfonoxyhexane 3,4,5,6,7-hexahydro-1H-azepine is obtained.

[실시예 23]Example 23

S-(-)-3-t-부틸옥시카르보닐메틸아미노피페리딘의 제조Preparation of S-(-)-3-t-butyloxycarbonylmethylaminopiperidine

S-(-)-2-t-부틸옥시카르보닐메틸아미노-디메탄술폰옥시펜탄을 이용하여 실시예 19과 같은 방법에 의해 S-(-)-3-t-부틸옥시카르보닐메틸아미노 피페리딘이 얻어진다.S-(-)-3-t-butyloxycarbonylmethylamino pi using the same method as in Example 19 using S-(-)-2-t-butyloxycarbonylmethylamino-dimethanesulfonoxypentane Ferridine is obtained.

[실시예 24]Example 24

S-(-)-3-t-부틸옥시카르보닐메틸아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀의 제조Preparation of S-(-)-3-t-butyloxycarbonylmethylamino-2,3,4,5,6,7-hexahydro-1H-azepine

S-(-)-2-t-부틸옥시카르보닐메틸아미노-디메탄술폰옥시헥산을 이용하여 실시예 20과 같은 방법에 의해 S-(-)-3-t-부틸옥시카르보닐메틸아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀이 얻어진다.S-(-)-3-t-butyloxycarbonylmethylamino- by the same method as in Example 20 using S-(-)-2-t-butyloxycarbonylmethylamino-dimethanesulfonoxyhexane 2,3,4,5,6,7-hexahydro-1H-azepine is obtained.

[실시예 25]Example 25

S-(-)-1-벤질-3-t-부록시카르보닐아미노 피페리딘S-(-)-1-benzyl-3-t-butoxycarbonylamino piperidine

디메탄술폰옥시 펜탄 유도체 1당량을 디클로로메탄에 녹인후 벤질아민 2∼5당량과 소디움카보네이트 1∼3당량을 넣고 50∼55℃에서 교반한다. 이 반응혼합물을 여과한 후 포화된 소디움히드로젠카보네이트 수용액으로 세 번 세척한 다음, 무수 마그네슘설페이트:포타슘카보네이트(1:1)로 건조하고 감압하에서 유기용매를 제거한다. 얻어진 잔사를 관크로마토그래피(헥산:에틸아세테이트=4:1)로 분리 또는 히드로클로라이드와 염을 형성시켜 결정을 얻은 후 히드로클로라이드를 제거하여 S-(-)-3-t-부틸옥시카르보닐아미노 피페리딘을 얻었다.After dissolving 1 equivalent of dimethanesulfonoxy pentane derivative in dichloromethane, 2-5 equivalents of benzylamine and 1-3 equivalents of sodium carbonate are added and stirred at 50-55 ° C. The reaction mixture was filtered, washed three times with saturated aqueous sodium hydrogencarbonate solution, dried over anhydrous magnesium sulfate: potassium carbonate (1: 1), and the organic solvent was removed under reduced pressure. The obtained residue was separated by column chromatography (hexane: ethyl acetate = 4: 1), or a salt was formed with a hydrochloride to obtain crystals. The hydrochloride was removed to remove S-(-)-3-t-butyloxycarbonylamino Obtained piperidine.

[실시예 26]Example 26

S-(-)-1-벤질-3-t-부톡옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀의 제조Preparation of S-(-)-1-benzyl-3-t-butoxyoxycarbonylamino-2,3,4,5,6,7-hexahydro-1H-azepine

디메탄술폰옥시 헥산 유도체 1당량을 디클로로메탄에 녹인후 벤질아민 2∼5당량과 소디움카보네이트 1∼3당량을 넣고 50∼55℃에서 환류교반한다. 이 반응혼합물을 여과한 후 포화된 소디움히드로젠카보네이트 수용액으로 세 번 세척한 다음, 무수 마그네슘설페이트:포타슘카보네이트(1:1)로 건조하고 감압하에서 유기용매를 제거한다. 얻어진 잔사를 관크로마토그래피(헥산:에틸아세테이트=4:1)로 분리 또는 히드로클로라이드와 염을 형성시켜 결정을 얻은 후 히드로클로라이드를 제거하여 S-(-)-1-벤질-3-t-부틸옥시카르보닐아미노-2,3,4,5,6,7-헥사히드로-1H-아제핀을 얻었다.One equivalent of dimethanesulfonoxy hexane derivative is dissolved in dichloromethane, and then 2 to 5 equivalents of benzylamine and 1 to 3 equivalents of sodium carbonate are stirred under reflux at 50 to 55 ° C. The reaction mixture was filtered, washed three times with saturated aqueous sodium hydrogencarbonate solution, dried over anhydrous magnesium sulfate: potassium carbonate (1: 1), and the organic solvent was removed under reduced pressure. The obtained residue was separated by column chromatography (hexane: ethyl acetate = 4: 1), or a salt was formed with a hydrochloride to obtain crystals. The hydrochloride was removed to remove S-(-)-1-benzyl-3-t-butyl Oxycarbonylamino-2,3,4,5,6,7-hexahydro-1H-azepine was obtained.

Claims (5)

L-글루타민산 및 L-아디픽산과 그들의 광학이성질체를 선택적 보호방법에 의해 아미노기와 카르복실기를 보호시켜 일반식(II)의 아미노산 유도체를 합성하고,L-glutamic acid and L-adipic acid and their optical isomers are protected by amino and carboxyl groups by a selective protection method to synthesize amino acid derivatives of general formula (II), 일반식(II)를 카르복실보호기의 선택적인 환원에 의해 광학활성이 있는 일반식(III)의 2-아미노-알칸디올 유도체를 제조하고,Preparing a 2-amino-alkanediol derivative of general formula (III) having optical activity by selective reduction of the general formula (II) with a carboxyl protecting group, 일반식(III)의 디올화합물을 친핵성 치환반응이 잘 일어날 수 있는 보호기로 바꾸어 일반식(IV)의 화합물로 변화시키고,The diol compound of general formula (III) is changed to a compound of general formula (IV) by changing into a protecting group that can easily undergo a nucleophilic substitution reaction, 일반식(IV)의 보호된 2-아미노-알칸디올의 술포닐유도체를 아민유도체와 반응시켜 광학활성이 있는 보호된 일반식(I)의 3-아미노 헤테로고리 아민유도체의 제조방법.A process for preparing 3-amino heterocyclic amine derivative of protected general formula (I) having optical activity by reacting a sulfonyl derivative of protected 2-amino-alkanediol of general formula (IV) with an amine derivative. 상기식에서, n은 1 또는 2, R1은 탄소수 1-6의 저급 알킬, R2은 수소 또는 탄소수 1-6의 저급 알킬, R3은 저급 알킬, 벤질옥시카르보닐, 특히 t-부틸옥시카르보닐, R4는 톨루엔기 또는 메틸을 나타내며, R5는 수소 또는 벤질, (R)-또는 (S)-페닐에틸, 벤즈히드릴기를 나타낸다.Wherein n is 1 or 2, R 1 is lower alkyl of 1-6 carbon atoms, R 2 is hydrogen or lower alkyl of 1-6 carbon atoms, R 3 is lower alkyl, benzyloxycarbonyl, in particular t-butyloxycarbon Bonyl, R 4 represents a toluene group or methyl, R 5 represents hydrogen or benzyl, (R)-or (S) -phenylethyl, benzhydryl group. 제1항에 있어서 일반식(III)의 화합물 제조시 사용되는 환원시약은 리튬알루미늄 히드라이드 또는 칼슘클로라이드와 소디움보로히드리드의 혼합물임을 특징으로 하는 일반식(I)의 3-아미노 헤테로고리아민유도체의 제조방법.The 3-amino heterocyclic amine of formula (I) according to claim 1, wherein the reducing reagent used in the preparation of the compound of formula (III) is lithium aluminum hydride or a mixture of calcium chloride and sodium borohydride. Process for the preparation of derivatives. 제1항에 있어서, 일반식(IV)의 화합물 제조시 메틸렌클로라이드 등의 유기할라이드 용매하에서 트리에틸아민, 피리딘등의 염기를 이용함을 특징으로 하는 일반식(I)의 3-아미노 헤테로고리아민유도체의 제조방법.The 3-amino heterocyclic amine derivative of the general formula (I) according to claim 1, wherein a triethylamine, pyridine or the like is used in an organic halide solvent such as methylene chloride in the preparation of the compound of the general formula (IV). Manufacturing method. 제1항에 있어서, 일반식(IV)의 화합물을 일반식(I)의 화합물로 폐환시 사용되는 염기로는 암모니아, 포타슘카보네이트 또는 소디움카보네이트를 사용함을 특징으로 하는 일반식(I)의 3-아미노 헤테로고리아민유도체의 제조방법.3. The compound of formula (I) according to claim 1, wherein a base used for ring-closing the compound of formula (IV) to the compound of formula (I) uses ammonia, potassium carbonate or sodium carbonate. Method for preparing amino heterocyclic amine derivative. 제1항에 있어서, 일반식(IV)의 화합물을 일반식(I)의 화합물로 폐환시 사용되는 용매는 물, 에탄올, 아세토니트릴, 디클로로메탄 등을 단독 또는 혼합액으로 사용함을 특징으로 하는 일반식(I)의 3-아미노 헤테로고리아민유도체 유도체의 제조방법.The method of claim 1, wherein the solvent used when the compound of formula (IV) is closed with the compound of formula (I) is water, ethanol, acetonitrile, dichloromethane, or the like. A method for producing the 3-amino heterocyclic amine derivative derivative of (I).
KR1019950012330A 1995-05-18 1995-05-18 A process for preparing stereo active 3-amino heterocyclic compound KR0150566B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950012330A KR0150566B1 (en) 1995-05-18 1995-05-18 A process for preparing stereo active 3-amino heterocyclic compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950012330A KR0150566B1 (en) 1995-05-18 1995-05-18 A process for preparing stereo active 3-amino heterocyclic compound

Publications (2)

Publication Number Publication Date
KR960041163A KR960041163A (en) 1996-12-19
KR0150566B1 true KR0150566B1 (en) 1998-10-15

Family

ID=19414765

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950012330A KR0150566B1 (en) 1995-05-18 1995-05-18 A process for preparing stereo active 3-amino heterocyclic compound

Country Status (1)

Country Link
KR (1) KR0150566B1 (en)

Also Published As

Publication number Publication date
KR960041163A (en) 1996-12-19

Similar Documents

Publication Publication Date Title
US3976680A (en) Production of an ester of one enantiomer of an α-amino acid in the form of a salt with an optically active acid
US6025516A (en) Resolution of 2-hydroxy-3-amino-3-phenylpropionamide and its conversion to C-13 sidechain of taxanes
US6197998B1 (en) Process for producing N-glycyltyrosine and its crystal structure
KR0150566B1 (en) A process for preparing stereo active 3-amino heterocyclic compound
ES2375384T3 (en) ASIMADOLINE FOR THE TREATMENT OF IRRITABLE COLON SYNDROME (IRRITABLE BOWEL SYNDROES).
EP1554235B1 (en) Process for synthesizing l-y-methylene glutamic acid and analogs
KR102589305B1 (en) Improved manufacturing method of sitagliptin phosphate salt
US6538160B2 (en) Process for producing α-aminohalomethyl ketone derivatives
US20040039224A1 (en) T-butoxycarbonylaminoethylamine for the synthesis of pna monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
EP1182199B1 (en) Process for preparing amic acid esters
KR0136706B1 (en) Process for 3-amino pyrrolidine derivatives
KR100554085B1 (en) Optically active aziridine-2-carboxylate derivatives and a process for preparing them
AU770530B2 (en) Process for the production of N-protected azetidine-2-carboxylic acids (AzeOHs)
US6891046B2 (en) Solution and solid phase synthesis of pyrrolinones and polypyrrolinones
US5929242A (en) Manufacture of levobupivacaine and analogues thereof from L-lysine
CN111943893B (en) Synthesis method of 4, 7-diazaspiro [2,5] octane compound
JPH0649005A (en) Simple method for producing vinylglycine (2-amino-3- butenoic acid) and simple method for dividing derivative
KR100566896B1 (en) Processes for the preparation of an optically active 5,6-dioxopiperazine-2-carboxylic acid derivative
KR102152445B1 (en) Production method of intermediate compound for synthesizing medicament
JP3518627B2 (en) Method for producing optically active 5-hydroxymethyloxazolidinone derivative
KR100288404B1 (en) 2-Benzothiazolyl 4-amino-5-chloro-2-methoxythiobenzoate And Process For Preparing Cisapride Employing The Same
JPH021446A (en) Preparation of n-hydroxy-alpha-amino acid and its derivative, and compound thus obtained
KR0140323B1 (en) PROCESS FOR PREPARING OPTICAL ACTIVE Ñß-AMINOACID
JP4524845B2 (en) Method for producing optically active allyl alcohol derivative having amino group, and optically active compound
JPH05255230A (en) New beta-alanine derivative and its production and production of glutamic acid blocking agent

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040607

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee